FBN1 and teratoma: Expression of FBN-1 in all subtypes of TGCTs (seminoma, embryonal carcinoma, yolk sac tumour, teratoma, choriocarcinoma) was significantly lower in comparison to the expression in GCNIS (Table 2, Fig. 1).